Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 359

1.

Dextromethorphan is protective against sensitized N-methyl-D-aspartate receptor-mediated excitotoxic brain damage in the developing mouse brain.

Keller M, Griesmaier E, Auer M, Schlager G, Urbanek M, Simbruner G, Gressens P, Sárközy G.

Eur J Neurosci. 2008 Feb;27(4):874-83. doi: 10.1111/j.1460-9568.2008.06062.x. Epub 2008 Feb 13.

PMID:
18279363
2.

Neuroprotective effects of the sigma-1 receptor ligand PRE-084 against excitotoxic perinatal brain injury in newborn mice.

Griesmaier E, Posod A, Gross M, Neubauer V, Wegleiter K, Hermann M, Urbanek M, Keller M, Kiechl-Kohlendorfer U.

Exp Neurol. 2012 Oct;237(2):388-95. doi: 10.1016/j.expneurol.2012.06.030. Epub 2012 Jul 6.

PMID:
22771763
3.

Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation.

Liu Y, Qin L, Li G, Zhang W, An L, Liu B, Hong JS.

J Pharmacol Exp Ther. 2003 Apr;305(1):212-8.

4.

Ontogenic study of the influence of tissue plasminogen activator (t-PA) in neonatal excitotoxic brain insult and the subsequent microglia/macrophage activation.

Hennebert O, Laudenbach V, Laquerriere A, Verney C, Carmeliet P, Marret S, Leroux P.

Neuroscience. 2005;130(3):697-712.

PMID:
15590153
5.

The AMPA receptor positive allosteric modulator, S18986, is neuroprotective against neonatal excitotoxic and inflammatory brain damage through BDNF synthesis.

Destot-Wong KD, Liang K, Gupta SK, Favrais G, Schwendimann L, Pansiot J, Baud O, Spedding M, Lelièvre V, Mani S, Gressens P.

Neuropharmacology. 2009 Sep;57(3):277-86. doi: 10.1016/j.neuropharm.2009.05.010. Epub 2009 Jun 6.

PMID:
19501111
6.

T3 replacement does not prevent excitotoxic cell death but reduces developmental neuronal apoptosis in newborn mice.

Sárközy G, Griesmaier E, He X, Kapelari K, Urbanek M, Simbruner G, Gressens P, Keller M.

Eur J Paediatr Neurol. 2007 May;11(3):129-35. Epub 2007 Jan 11.

PMID:
17222575
7.

Erythropoietin is neuroprotective against NMDA-receptor-mediated excitotoxic brain injury in newborn mice.

Keller M, Yang J, Griesmaier E, Gorna A, Sarkozy G, Urbanek M, Gressens P, Simbruner G.

Neurobiol Dis. 2006 Nov;24(2):357-66. Epub 2006 Sep 7.

PMID:
16959492
8.

Central role of microglia in neonatal excitotoxic lesions of the murine periventricular white matter.

Tahraoui SL, Marret S, Bodénant C, Leroux P, Dommergues MA, Evrard P, Gressens P.

Brain Pathol. 2001 Jan;11(1):56-71.

PMID:
11145204
9.

Neuroprotective effects of NAP against excitotoxic brain damage in the newborn mice: implications for cerebral palsy.

Sokolowska P, Passemard S, Mok A, Schwendimann L, Gozes I, Gressens P.

Neuroscience. 2011 Jan 26;173:156-68. doi: 10.1016/j.neuroscience.2010.10.074. Epub 2010 Nov 10.

PMID:
21073926
10.

Neuroprotective effects vary across nonsteroidal antiinflammatory drugs in a mouse model of developing excitotoxic brain injury.

Leroux P, Hennebert C, Catteau J, Legros H, Hennebert O, Laudenbach V, Marret S.

Neuroscience. 2010 May 19;167(3):716-23. doi: 10.1016/j.neuroscience.2010.02.042. Epub 2010 Feb 24.

PMID:
20188153
11.

The sigma-1 receptor agonist 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) protects against newborn excitotoxic brain injury by stabilizing the mitochondrial membrane potential in vitro and inhibiting microglial activation in vivo.

Wegleiter K, Hermann M, Posod A, Wechselberger K, Stanika RI, Obermair GJ, Kiechl-Kohlendorfer U, Urbanek M, Griesmaier E.

Exp Neurol. 2014 Nov;261:501-9. doi: 10.1016/j.expneurol.2014.07.022. Epub 2014 Aug 8.

PMID:
25111531
12.

Effects of alpha(2)-adrenoceptor agonists on perinatal excitotoxic brain injury: comparison of clonidine and dexmedetomidine.

Laudenbach V, Mantz J, Lagercrantz H, Desmonts JM, Evrard P, Gressens P.

Anesthesiology. 2002 Jan;96(1):134-41.

PMID:
11753013
13.

Methylphenidate and MK-801, an N-methyl-d-aspartate receptor antagonist: shared biological properties.

Husson I, Mesplès B, Medja F, Leroux P, Kosofsky B, Gressens P.

Neuroscience. 2004;125(1):163-70.

PMID:
15051155
14.

The effects of dexmedetomidine on perinatal excitotoxic brain injury are mediated by the alpha2A-adrenoceptor subtype.

Paris A, Mantz J, Tonner PH, Hein L, Brede M, Gressens P.

Anesth Analg. 2006 Feb;102(2):456-61.

PMID:
16428542
16.

Fructose-1,6-biphosphate prevents excitotoxic neuronal cell death in the neonatal mouse brain.

Rogido M, Husson I, Bonnier C, Lallemand MC, Mérienne C, Gregory GA, Sola A, Gressens P.

Brain Res Dev Brain Res. 2003 Feb 16;140(2):287-97.

PMID:
12586434
17.

Early microglial activation following neonatal excitotoxic brain damage in mice: a potential target for neuroprotection.

Dommergues MA, Plaisant F, Verney C, Gressens P.

Neuroscience. 2003;121(3):619-28.

PMID:
14568022
18.

Delayed white matter injury in a murine model of shaken baby syndrome.

Bonnier C, Mesplès B, Carpentier S, Henin D, Gressens P.

Brain Pathol. 2002 Jul;12(3):320-8.

PMID:
12146800
19.

The common antitussive agent dextromethorphan protects against hyperoxia-induced cell death in established in vivo and in vitro models of neonatal brain injury.

Posod A, Pinzer K, Urbanek M, Wegleiter K, Keller M, Kiechl-Kohlendorfer U, Griesmaier E.

Neuroscience. 2014 Aug 22;274:260-72. doi: 10.1016/j.neuroscience.2014.05.059. Epub 2014 Jun 6.

PMID:
24912029
20.

Novel regimen through combination of memantine and tea polyphenol for neuroprotection against brain excitotoxicity.

Chen CM, Lin JK, Liu SH, Lin-Shiau SY.

J Neurosci Res. 2008 Sep;86(12):2696-704. doi: 10.1002/jnr.21706.

PMID:
18478543

Supplemental Content

Support Center